Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response, offering new insight that can potentially help improve the effectiveness of cancer immunotherapy.
Unraveling the mystery of cancer resistance
Every multicellular creature -; whether soaring through the skies, swimming in the ocean’s depths or roaming the earth’s surface -; shares a common vulnerability: the
October 29, 2024